Safety and efficacy of pomalidomide, dexamethasone and pegylated liposomal doxorubicin for patients with relapsed or refractory multiple myeloma. [electronic resource]
Producer: 20180222Description: 60-70 p. digitalISSN:- 1365-2141
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Dexamethasone -- administration & dosage
- Doxorubicin -- administration & dosage
- Drug Resistance, Neoplasm
- Female
- Humans
- Male
- Middle Aged
- Multiple Myeloma -- drug therapy
- Polyethylene Glycols -- administration & dosage
- Recurrence
- Retreatment
- Survival Analysis
- Thalidomide -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.